Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
22 Cards in this Set
- Front
- Back
primary prevention
|
prevention of first occurrence of cardiovascular disease
more expensive because many treated people will never get the disease regardless risk factor evaluation at age 18 |
|
2ndary prevention
|
prevention of 2nd occurance of CVD
vigorous risk modification better money spent |
|
nonmodifiable risk factors
|
age - older
sex - men before 70, women after 70 family history - smoking/dietary habits learned, genetics, |
|
modifiable risk factors
|
smoking - #1
hypertension lipid abnormalities (cholesterol) diabetes others: obesity phys infactivity left ventricular hypertrophy |
|
magnitude of risk is determined by
|
amount of a given risk factor
number of risk factors over the lifetime |
|
number of risk factors
|
2 risk factors doubles a person risk
3 risk factors = 4x the risk removing one risk factor is a huge change |
|
risk markers
|
associated with development of artheroscleosis but NOT CAUSITIVE
altering a risk marker does not affect progression or regression of disease e.g. homocystine, uric acid |
|
global risk score
|
assess primary risk only - not secondary risk
e.g. framingham risk scores high risk = 20% or greater risk of event in 10 years intermediate = 10-19% low risk < 10% |
|
current guidelines on risk factor identification
|
every five years after 18 determine risk factors
global risk score every 5 years after 35 for males and 45 for female |
|
primary prevention of atherosclerosis
|
lifestyle behavior change even more valuable than any drug
smoking cessation, eat less drugs: weigh cost, toxicity, treat more people to prevent events |
|
2ndary prevention of atherosclerosis
|
individuals with CVD
single greatest benefit = smoking cessation lifestyle more aggressive lipid targeting diabetes over 40 should be considered for 2ndary prevention |
|
T/F atherosclerosis is a systemic illness
|
true
likely if you have atherosclerotic disease in one area (like in periphery), likely to have coronary artery disease |
|
patient adherence
|
intervention is long term and sustained
|
|
smoking effects on atherosclerosis
|
effects endothelial function and vasomotion
plaque formation |
|
hypertension effect on atherosclerosis
|
elevation of either systolic or diastolic pressure
lifestyle and medication DASH diet |
|
hyperlipidemia
|
lipid metabolic abnormalities are often genetically biased
diet and inactivity -> overexpression of abnormalities |
|
LDL
|
LDL is major component of plaque - most associated with atherosclerotic plaque formation
most useful drug target control of LDL will cause already formed plaques to regress caused by increased calories and saturated fats |
|
HDL
|
inversely associated with atherosclerosis
reverse cholesterol transport from tissue to liver disposal too high levels not good |
|
triglycerides
|
2ndary drug target
TGs make LDL more atherogenic made worse with high carbs linked with metabolic syndrome and diabetes |
|
metabolic syndrome
|
cluster of risk factors
defined by: abdominal obesity hypertension glucose intolerance (prediabets or diabetes) lipid abnormalities - high TGs and depressed HDL insulin resistance link |
|
diabetes
|
want to control glucose, BUT most important is controlling macrovascular effects
macrovascular effects contributes the most to deaths and includes eyes, peripheral nevers, and kidney control LDL, BP, smoking is important |
|
need to focus on what 3 things to reduce atherosclerosis
|
exercise
diet smoking |